Paul J. Bloem (Switzerland)

TBA TBA

Moderator of 1 Session

Conference Calendar

Public Health Oral Session

00690 - Oral Session 5: VACCINATION II. Implementation, dissemination, and communication (ID 32)

Session Type

Public Health Oral Session

Session Date

07/22/2020

Session Time

08:45 - 10:10

Room

Hall F

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"TAILORING TAILORED MESSAGES? EFFECTIVENESS OF TAILORED MESSAGES TO IMPROVE BEHAVIORAL INTENT TO ACCEPT HUMAN PAPILLOMAVIRUS (HPV) VACCINATION MAY BE MODERATED BY SOCIODEMOGRAPHIC FACTORS. \u003Csmall\u003E(ID 913)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":913,"presentation":"TAILORING TAILORED MESSAGES? EFFECTIVENESS OF TAILORED MESSAGES TO IMPROVE BEHAVIORAL INTENT TO ACCEPT HUMAN PAPILLOMAVIRUS (HPV) VACCINATION MAY BE MODERATED BY SOCIODEMOGRAPHIC FACTORS. \u003Csmall\u003E(ID 913)\u003C\/small\u003E","session":"Oral Session 5: VACCINATION II. Implementation, dissemination, and communication","presenter":"Gregory Zimet (United States of America)","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/IPVC20 - PRESENTATION id 913.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/32\/IPVC20 - PRESENTATION id 913.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/E2B37F6F.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/IPVC20 - PRESENTATION id 913.vtt"}]},{"name":"INFLUENZA VACCINE VISITS ARE AN UNDERUTILIZED AVENUE FOR INCREASING HUMAN PAPILLOMA VIRUS VACCINATION RATES: AN AAP PEDIATRIC RESEARCH IN OFFICE SETTINGS (PROS) NETWORK STUDY \u003Csmall\u003E(ID 1159)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1159,"presentation":"INFLUENZA VACCINE VISITS ARE AN UNDERUTILIZED AVENUE FOR INCREASING HUMAN PAPILLOMA VIRUS VACCINATION RATES: AN AAP PEDIATRIC RESEARCH IN OFFICE SETTINGS (PROS) NETWORK STUDY \u003Csmall\u003E(ID 1159)\u003C\/small\u003E","session":"Oral Session 5: VACCINATION II. Implementation, dissemination, and communication","presenter":"Alexander Fiks (United States of America)","photo":""},"playlist":[{"name":"INFLUENZA VACCINE VISITS ARE AN UNDERUTILIZED AVENUE FOR INCREASING HUMAN PAPILLOMA VIRUS VACCINATIO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/1159.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/32\/1159.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/9928E061.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/1159.vtt"}]},{"name":"THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN MANAGING THE RISK OF VACCINE HESITANCY IN A STUDY OF SINGLE-DOSE HPV VACCINATION \u003Csmall\u003E(ID 1288)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1288,"presentation":"THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN MANAGING THE RISK OF VACCINE HESITANCY IN A STUDY OF SINGLE-DOSE HPV VACCINATION \u003Csmall\u003E(ID 1288)\u003C\/small\u003E","session":"Oral Session 5: VACCINATION II. Implementation, dissemination, and communication","presenter":"Lerato Makhale (South Africa)","photo":""},"playlist":[{"name":"THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN MANAGING THE RISK OF VACCINE HESITANCY IN A STUDY OF SINGL","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/Lerato Makhale IPVC20 1288.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/32\/Lerato Makhale IPVC20 1288.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/69D1E536.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/Lerato Makhale IPVC20 1288.vtt"}]},{"name":"UNDERSTANDING DATA SYSTEMS THAT ENABLE ASSESSMENT OF THE IMPACT OF HPV VACCINATION IN HIGH-INCOME COUNTRIES \u003Csmall\u003E(ID 1331)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1331,"presentation":"UNDERSTANDING DATA SYSTEMS THAT ENABLE ASSESSMENT OF THE IMPACT OF HPV VACCINATION IN HIGH-INCOME COUNTRIES \u003Csmall\u003E(ID 1331)\u003C\/small\u003E","session":"Oral Session 5: VACCINATION II. Implementation, dissemination, and communication","presenter":"Renna Patel (United States of America), Smita Kothari (United States of America)","photo":""},"playlist":[{"name":"UNDERSTANDING DATA SYSTEMS THAT ENABLE ASSESSMENT OF THE IMPACT OF HPV VACCINATION IN HIGH-INCOME CO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/1331 Smita Kothari.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/32\/1331 Smita Kothari.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/F5E35F2C.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/1331 Smita Kothari.vtt"}]},{"name":"AFTER THE SUSPENSION OF THE PROACTIVE HPV VACCINE RECOMMENDATION BY THE JAPANESE GOVERNMENT; WHAT HAPPENED AND WHAT IS HAPPENING IN JAPAN? \u003Csmall\u003E(ID 458)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":458,"presentation":"AFTER THE SUSPENSION OF THE PROACTIVE HPV VACCINE RECOMMENDATION BY THE JAPANESE GOVERNMENT; WHAT HAPPENED AND WHAT IS HAPPENING IN JAPAN? \u003Csmall\u003E(ID 458)\u003C\/small\u003E","session":"Oral Session 5: VACCINATION II. Implementation, dissemination, and communication","presenter":"Etsuko Miyagi (Japan)","photo":""},"playlist":[{"name":"AFTER THE SUSPENSION OF THE PROACTIVE HPV VACCINE RECOMMENDATION BY THE JAPANESE GOVERNMENT; WHAT HA","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/Etsuko Miyagi - IPVC20 - Presentation 458.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/32\/Etsuko Miyagi - IPVC20 - Presentation 458.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/A3AF6BD6.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/Etsuko Miyagi - IPVC20 - Presentation 458.vtt"}]},{"name":"THE LONG-TERM IMPACT AND CLINICAL OUTCOMES OF FEWER VERSUS STANDARD DOSES OF HUMAN PAPILLOMAVIRUS VACCINE IN THE UNITED STATES: A DATABASE STUDY - author request \u003Csmall\u003E(ID 252)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":252,"presentation":"THE LONG-TERM IMPACT AND CLINICAL OUTCOMES OF FEWER VERSUS STANDARD DOSES OF HUMAN PAPILLOMAVIRUS VACCINE IN THE UNITED STATES: A DATABASE STUDY - author request \u003Csmall\u003E(ID 252)\u003C\/small\u003E","session":"Oral Session 5: VACCINATION II. Implementation, dissemination, and communication","presenter":"Ana M. Rodriguez (United States of America)","photo":""},"playlist":[{"name":"P252_THE LONG-TERM IMPACT AND CLINICAL OUTCOMES OF FEWER VERSUS STANDARD DOSES OF HUMAN PAPILLOMAVIR","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/P252_THE LONG-TERM IMPACT AND CLINICAL OUTCOMES OF FEWER VERSUS STANDARD DOSES OF HUMAN PAPILLOMAVIRUS VACCINE IN THE UNITED STATES A DATABASE STUDY.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/32\/P252_THE LONG-TERM IMPACT AND CLINICAL OUTCOMES OF FEWER VERSUS STANDARD DOSES OF HUMAN PAPILLOMAVIRUS VACCINE IN THE UNITED STATES A DATABASE STUDY.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/341590CD.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/32\/P252_THE LONG-TERM IMPACT AND CLINICAL OUTCOMES OF FEWER VERSUS STANDARD DOSES OF HUMAN PAPILLOMAVIRUS VACCINE IN THE UNITED STATES A DATABASE STUDY.vtt"}]}]